Day: February 21, 2021

NMPA Approves Toripalimab in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma after Failure of at Least Two Lines of Prior Systemic Therapy

— 1stapproval of any checkpoint inhibitor in nasopharyngeal carcinoma in the world— 2ndindication approved for Toripalimab in ChinaSHANGHAI, China, Feb. 22, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the National Medical Products Administration (NMPA) of China has granted a conditional approval to toripalimab for the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma (NPC) after failure of at least two lines of prior systemic therapy. This is the first approval of immune checkpoint blockade therapy in NPC in the world and the second approved indication for toripalimab in China. In December 2018, Toripalimab obtained...

Continue reading

Consolidated Unaudited Interim Report of AS PRFoods for the 2nd quarter and 6 months of 2020/2021 financial year

MANAGEMENT COMMENTARYSecond half of 2020 is characterized by continuation of COVID crisis. Salmon prices are 12-year low and compared to the same period last year, salmon prices are down 38% and rainbow trout is down by 22.5%. Adding to this global decrease in demand due to shutdown of HoReCa and you can call the situation as „perfect storm“. Companies who emerge from this crisis unscathed will be future winners. Arrival of vaccines is giving hope that we can see some normalization during 2nd half of 2021. 2022 will definitely be more profitable year in Fish farming as farmers can plan better the demand. Today’s farming volumes were planned before crisis and therefore there is massive oversupply in the market and most Fish farmers operate either at loss or at break-even. John Ross Jr has shown extraordinary resilience in current crisis...

Continue reading

AS-i PRFoods 2020/2021. majandusaasta 2. kvartali ja kuue kuu konsolideeritud auditeerimata vahearuanne

JUHTKONNA KOMMENTAAR2020 II poolaastat ilmestas COVID kriisi jätkumine. Lõheliste hinnad on 12- aasta madalaimad ning võrreldes eelmise aasta sama perioodiga ligi 38% madalam lõhel ning 22.5% madalam forellil. Siia tuleb veel lisada ülemaailmne nõudluse vähenemine HoReCa sektori sulgemise tõttu ning seega võib antud olukorda nimetada „täiuslik torm“. Ettevõtted, kes sellest kriisist väljuvad tervelt, on kindlasti tulevikus võitjad. Vaktsiinide tulek annab lootust, et 2021 II poolaastas võime näha mingit normaliseerumist ning nõudluse taastumist. 2022 on kalakasvatustel kindlasti kasumlikum aasta, sest kasvatajad oskavad paremini nõudlust planeerida. Tänased kasvatusmahud olid planeeritud enne kriisi ning sellest tulenevalt on turul massiivne ülepakkumine ning enamus kalakavatussektorist toimib kas kahjumlikult või omahinna piires. John...

Continue reading

Practus Appoints Deepak Narayanan as CEO

The Practus Board announced the appointment of Deepak Narayanan as CEO with immediate effect. Founded by S. Venkataraman and Deepak Narayanan, Practus with presence across North America, the Middle East, Africa & India (operates under the brand name MYCFO and MyCXO), is a leading Business and Finance Advisory firm, that assists the clients to transform their Finance and Business operations. The CEO appointment will accelerate the group expansion to the next level of growth, aided by faster decision-making, a responsibility which was jointly shouldered by the Co-Founders till date “Practus has been growing rapidly, and as we enter new markets and explore new territories, given Deepak’s strong command over the business and proven ability to drive results, makes him the right person to provide a focused, responsive, and decisive direction...

Continue reading

Disclaimer & Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.